Molekulare zielgerichtete Therapie und Immuntherapie des Prostatakarzinoms
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://link.springer.com/content/pdf/10.1007/s00120-020-01198-6.pdf
Reference42 articles.
1. Corcoran NM et al (2016) Molecular pathways: targeting DNA repair pathway defects enriched in metastasis. Clin Cancer Res 22(13):3132–3137
2. Li GM (2008) Mechanisms and functions of DNA mismatch repair. Cell Res 18(1):85–98
3. Sahin IH et al (2019) Immune checkpoint inhibitors for the treatment of MSI-H/MMR‑D colorectal cancer and a perspective on resistance mechanisms. Br J Cancer 121(10):809–818
4. McLennan D et al (2020) Re: PROREPAIR-B: a prospective cohort study of the impact of germline DNA repair mutations on the outcomes of patients with metastatic castration-resistant prostate cancer. Eur Urol 77(1):130–131
5. Nientiedt C et al (2017) Mutations in BRCA2 and taxane resistance in prostate cancer. Sci Rep 7(1):4574
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molekulares Tumorboard – Prostatakarzinom;Die Urologie;2023
2. CACYBP knockdown inhibits progression of prostate cancer via p53;Journal of Cancer Research and Clinical Oncology;2022-12-28
3. Molekulares Tumorboard – Prostatakarzinom;Die Urologie;2022
4. Roles of circRNAs in prostate cancer: Expression, mechanism, application and potential;The International Journal of Biochemistry & Cell Biology;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3